GW Pharmaceuticals Receives Approval for 5 New Patents for Epidiolex | CashCropToday
0 Shares 210 Views

GW Pharmaceuticals Receives Approval for 5 New Patents for Epidiolex

March 15, 2018
210 Views

GW Pharmaceuticals (Nasdaq:GWPH) recently announced that their company has received “Notices of Allowance” from the United States Patent and Trademark office for five new Epidiolex® patent applications for the company’s proprietary Cannabidiol (CBD) based pharmaceutical.

Epidiolex® is concentrated on treating rare, treatement resistant epilepsy conditions such as Dravet syndrome, Lennox-Gastaut syndrome (LGS), Tuberous Sclerosis Complex (TSC) and Infantile Spasms (IS). GW Pharmaceuticals has submitted regulatory applications for Epidiolex® in both the United States and Europe.

By granting Epidiolex® the Orphan Drug Designation the FDA has already labeled it as a safe and an effective treatment for a rare disease or disorder. The FDA has set a PDUFA goal date of June 27, 2018.


List of the New Patents

US 15/449,084           
A method of reducing seizure frequency in a patient suffering from a treatment-resistant childhood-onset epilepsy selected from Lennox-Gastaut syndrome or Dravet syndrome and who was previously treated with clobazam, comprising administering CBD and clobazam to the patient in need thereof, wherein the dose of clobazam used in combination with the CBD is reduced relative to the dose of clobazam administered to the patient prior to treatment with the CBD, wherein the CBD has a purity of at least 98 percent (w/w) CBD and comprises not more than 0.15 percent (w/w) THC.

US 15/449,124
A method of reducing seizure frequency in a patient with a treatment-resistant epilepsy, which is Lennox-Gastaut syndrome, comprising administering to the patient in need thereof clobazam and CBD, wherein the purity of the CBD is at least 98 percent (w/w) CBD and comprises not more than 0.15 percent (w/w) THC, wherein the dose of the CBD is at least 10 mg/kg/day.

US 15/449,185
A method of reducing seizure frequency in a patient with a treatment-resistant epilepsy, which is Dravet syndrome, comprising administering to the patient in need thereof clobazam and CBD, wherein the purity of the CBD is at least 98 percent (w/w) CBD and comprises not more than 0.15 percent (w/w) THC, wherein the dose of the CBD is at least 10 mg/kg/day.

US 15/449,204
A method of reducing convulsive seizure frequency in a patient with a treatment-resistant epilepsy, which is Lennox-Gastaut syndrome, comprising administering to the patient in need thereof CBD, wherein the CBD has a purity of at least 98 percent (w/w) CBD and comprises not more than 0.15 percent (w/w) THC, wherein the dose of the CBD is at least 10 mg/kg/day.

US 15/449,177
A method of reducing convulsive seizure frequency in a patient with a treatment-resistant epilepsy, which is Dravet syndrome, comprising administering to the patient in need thereof CBD, wherein the CBD has a purity of at least 98 percent (w/w) CBD and comprises not more than 0.15 percent (w/w) THC, wherein the dose of the CBD is at least 10 mg/kg/day.


Link to the Press Release

You may be interested

Leafwire Launches Social Networking Cannabis and Hemp Platform
Tech
118 views
Tech
118 views

Leafwire Launches Social Networking Cannabis and Hemp Platform

Editor - July 20, 2018

Leafwire launched their new social platform this week which is dedicated to connect cannabis and industrial hemp investors, entrepreneurs, employees and upper management all under one network.…

Hawaii Issues First Industrial Hemp Licenses
Politics
170 views
Politics
170 views

Hawaii Issues First Industrial Hemp Licenses

Editor - July 20, 2018

The Hawaii Department of Agriculture (HDOA) has issued its first licenses to farmers to cultivate industrial hemp under the states pilot program. The government in Hawaii had…

The Green Organic Dutchman and Epican Open Retail Dispensary in Jamaica
Manufacturing
216 views
Manufacturing
216 views

The Green Organic Dutchman and Epican Open Retail Dispensary in Jamaica

Editor - July 19, 2018

The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (OTC:TGODF) and Epican Medicinals, announced this week that the companies have successfully opened their first legal cannabis retail store in the…

Leave a Comment

Your email address will not be published.

Most from this category

%d bloggers like this: